Biology of hematopoietic stem cells and progenitors: Implications for clinical application

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 759-806

  Kondo, Motonari ^a   Wagers, Amy J ^b   Manz, Markus G ^c   Prohaska, Susan S ^b   Scherer, David C ^d   Beilhack, Georg F ^b   Shizuru, Judith A ^b   Weissman, Irving L ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fondazione per l'Istituto di Ricerca in Biomedicina   (Switzerland)

^d Celtrans   (United States)

Author keywords

Bone marrow transplantation; Lineage commitment; Self renewal; Tolerance induction

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN;

ANGIOGENESIS; APOPTOSIS; BONE MARROW CELL; BONE MARROW DISEASE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CELL RENEWAL; CELL SELECTION; CLINICAL TRIAL; DIABETES MELLITUS; ERYTHROCYTE; GENE EXPRESSION PROFILING; GRANULOCYTE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; LYMPHOID CELL; MEGAKARYOCYTE; MONOCYTE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; ANIMAL; AUTOIMMUNE DISEASE; CELL DIVISION; CELL MOTION; CELL SEPARATION; CYTOLOGY; FEMALE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE; NEOPLASM;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; NEOPLASMS;

EID: 0038406789     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141007     Document Type: Review

References (325)

1. Jacobson LO, Marks EK, Gaston EO, Zirkle RE. 1949. Effect of spleen protection on mortality following x-irradiation. J. Lab. Clin. Med. 34:1538-43
2. Jacobson LO, Simmons EL, Marks EK, Eldredge JH. 1951. Recovery from radiation injury. Science 113:510-11
3. Lorenz E, Uphoff DE, Reid TR, Shelton E. 1951. Modification of acute irradiation injury in mice and guinea pigs by bone marrow injection. Radiology 58:863-77
4. van Bekkum DW, de Vries JJ. 1967. Radiation chemaeras. In Radiobiological Institute of the Organisation for Health Research TNO, ed. ZH Rijswijk. New York: Academic
5. Main JM, Prehn RT. 1955. Successful skin homografts after the administration of high dosage x-radiation and homologous bone marrow. J. Natl. Cancer Inst. 15:1023-29
6. Ford CE, Hamerton JL, Barnes DWH, Loutit JF. 1956. Cytological identification of radiation chimaeras. Nature 177:239-47
7. Till JE, McCulloch EA. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:213-22
8. Wu AM, Till JE, Siminovitch L, McCulloch EA. 1967. A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J. Cell Physiol. 69:177-84
9. Na Nakorn T, Traver D, Weissman IL, Akashi K. 2002. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109:1579-85
10. Becker A, McCulloch E, Till J. 1963. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452-54
11. Jordan CT, Lemischka IR. 1990. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4:220-32
12. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, Weissman IL. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124:1929-39
13. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661-73
14. - Sca-1+ cells are the only stem cells in C57BL/KaThy-1.1 bone marrow. J. Exp. Med. 175:175-84
15. Smith LG, Weissman IL, Heimfeld S. 1991. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 88:2788-92
16. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. 2003. Little evidence for develomental plasticity of adult hematopoietic stem cells. Science. 297:2256-59
17. Christensen JL, Weissman IL. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-56
18. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-45
19. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, et al. 1997. Dye effiux studies suggest that hematopoieric stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3:1337-45
20. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-806
21. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
22. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-97
23. Na Nakorn T, Miyamoto T, Weissman IL. 2002. Characterization of mouse clonogenic megakaryocyte progenitors. Proc. Natl. Acad. Sci. USA. In press
24. Kondo M, Scherer DC, King AG, Manz MG, Weissman IL. 2001. Lymphocyte development from hematopoietic stem cells. Curr. Opin. Genet. Dev. 11:520-26
25. Haar JL, Ackerman GA. 1971. A phase and electron microscopic study of vasculogenesis and erythropoiesis in the yolk sac of the mouse. Anat. Rec. 170:199-223
26. Yoder MC. 2001. Introduction: spatial origin of murine hematopoietic stem cells. Blood 98:3-5
27. Cumano A, Godin I. 2001. Pluripotent hematopoietic stem cell development during embryogenesis. Curr. Opin. Immunol. 13:166-71
28. Keller G, Lacaud G, Robertson S. 1999. Development of the hematopoietic system in the mouse. Exp. Hematol. 27:777-87
29. Dieterlen-Lievre F. 1975. On the origin of haemapoietic stem cells in the avian embryo: an experimental approach. J. Embryol. Exp. Morphol. 33:607-19
30. Dieterlen-Lievre F, Le Douarin N. 1993. Developmental rules in the hematopoietic and immune systems of birds: how general are they? Semin. Dev. Biol. 4:325-32
31. Medvinsky A, Dzierzak E. 1996. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86:897-906
32. Moore M, Owen J. 1967. Stem-cell migration in developing myeloid and lymphoid systems. Nature 215:1081-82
33. Moore M, Metcalf D. 1970. Ontogeny of the haematopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol. 18:279-96
34. Johnson G, Moore M. 1975. Role of stem cell migration in initiation of mouse fetal liver hematopoiesis. Nature 258:726-28
35. Weissman IL, Papaioannou V, Gardner R. 1978. Fetal hematopoietic origins of the adult hematolymphoid system. In Differentiation of Normal and Neoplastic Hematopoietic Cells, ed. B Clarkson, PA Marks, JE Till, pp. 33-47. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
36. Houssaint E. 1981. Differentiation of the mouse hepatic primordium II: extrinsic origin of the hematopoietic cell line. Cell Differ. 10:243-47
37. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93:3444-49
38. Kitajima K, Kojima M, Nakajima K, Kondo S, Hara T, et al. 1999. Definitive but not primitive hematopoiesis is impaired in jumonji mutant mice. Blood 93:87-95
39. Wu H, Liu X, Jaenisch R, Lodish HF. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67
40. Lin CS, Lim SK, D'Agati V, Costantini F. 1996. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10:154-64
41. Chui DH, Loyer BV. 1975. Foetal erythropoiesis in steel mutant mice. II. Haemopoietic stem cells in foetal livers during development. Br. J. Haematol. 29:553-65
42. Muller A, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. 1994. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1:291-301
43. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E. 2000. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 19:2465-74
44. Huang H, Auerbach R. 1993. Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc. Natl. Acad. Sci. USA 90:10110-14
45. Lu LS, Wang SJ, Auerbach R. 1996. In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded > 100-fold by coculture with a clonal yolk sac endothelial cell line. Proc. Natl. Acad. Sci. USA 93:14782-87
46. Muller AM, Dzierzak EA. 1993. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118:1343-51
47. Palis J, Yoder MC. 2001. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp. Hematol. 29:927-36
48. Yoder MC, Hiatt K. 1997. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 89:2176-83
49. Yoder MC, Hiatt K, Mukherjee P. 1997. In vivo repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus. Proc. Natl. Acad. Sci. USA 94:6776-80
50. Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. 1997. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 7:335-44
51. Wolf N, Bertoncello I, Jiang D, Priestley G. 1995. Developmental hematopoiesis from prenatal to young-adult life in the mouse model. Exp. Hematol. 23:142-46
52. Harrison D, Astle C. 1997. Short-and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood. Blood 89:2176-83
53. Ema H, Nakauchi H. 2000. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 95:2284-88
54. Matsuoka S, Tsuji K, Hisakawa H, Xu M, Ebihara Y, et al. 2001. Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells. Blood 98:6-12
55. Kyba M, Perlingeiro RC, Daley GQ. 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29-37
56. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, et al. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1753-65
57. Antonchuk J, Sauvageau G, Humphries RK. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45
58. Antonchuk J, Sauvageau G, Humphries RK. 2001. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol. 29:1125-34
59. Thorsteinsdottir U, Sauvageau G, Humphries RK. 1999. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94:2605-12
60. Helgason CD, Sauvageau G, Lawrence HJ, Largman C, Humphries RK. 1996. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87:2740-49
61. Kawabata K, Ujikawa M, Egawa T, Kawamoto H, Tachibana K, et al. 1999. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. USA 96:5663-67
62. Ma Q, Jones D, Springer TA. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10:463-71
63. Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, et al. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12:2392-402
64. Ikuta K, Weissman IL. 1993. T lymphocyte development from fetal hematopoietic stem cells. Semin. Dev. Biol. 4:371-78
65. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 92:10302-6
66. Clapp DW, Freie B, Lee W-H, Zhang Y-Y. 1995. Molecular evidence that in situ-transduced fetal liver hematopoietic stern/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood 86:2113-22
67. Zanjani E, Ascensao J, Tavassoli M. 1993. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 81:399-404
68. Jordan CT, Astle CM, Zawadzki J, Mackarehtschian K, Lemischka IR, Harrison DE. 1995. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp. Hematol. 23:1011-15
69. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:202-18
70. Ikuta K, Kina T, MacNeil I, Uchida N, Peault B, et al. 1990. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62:863-74
71. Havran WL, Allison JP. 1988. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335:443-45
72. - LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493-504
73. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. 1996. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 87:3500-7
74. Holyoake TL, Nicolini FE, Eaves CJ. 1999. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp. Hematol. 27:1418-27
75. Pawliuk R, Eaves C, Humphries RK. 1996. Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo. Blood 88:2852-58
76. Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. 1997. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp. Hematol. 25:293-97
77. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. 1996. The aging of hematopoietic stem cells. Nat. Med. 2:1011-16
78. Nishikawa SI. 2001. A complex linkage in the developmental pathway of endothelial and hematopoietic cells. Curr. Opin. Cell Biol. 13:673-78
79. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, et al. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981-90
80. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
81. Dickson MC, Marlin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-54
82. Kennedy M, Firpo M, Choi K, Wall C, Robertson S, et al. 1997. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386:488-93
83. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-32
84. Hamaguchi I, Huang XL, Takakura N, Tada J, Yamaguchi Y, et al. 1999. In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region. Blood 93:1549-56
85. Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N. 1999. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93:1253-63
86. Ogawa M, Kizumoto M, Nishikawa S, Fujimoto T, Kodama H, Nishikawa SI. 1999. Expression of alpha4-integrin defines the earliest precursor of hematopoietic cell lineage diverged from endothelial cells. Blood 93:1168-77
87. Nishikawa SI, Nishikawa S, Kawamoto H, Yoshida H, Kizumoto M, et al. 1998. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity 8:761-69
88. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H. 1998. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-57
89. Cheshier SH, Morrison SJ, Liao X, Weissman IL. 1999. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 96:3120-25
90. Ema H, Takano H, Sudo K, Nakauchi H. 2000. In vitro self-renewal division of hematopoietic stem cells. J. Exp. Med. 192:1281-88
91. Glimm H, Eaves CJ. 1999. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 94:2161-68
92. Fraser CC, Eaves CJ, Szilvassy SJ, Humphries RK. 1990. Expansion in vitro of retrovirally marked totipotent hematopoietic stem cells. Blood 76:1071-76
93. Miller CL, Eaves CJ. 1997. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lymphomyeloid reconstituting ability. Proc. Natl. Acad. Sci. USA 94:13648-53
94. Conneally E, Cashman J, Petzer A, Eaves C. 1997. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphomyeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94:9836-41
95. Yagi M, Ritchie KA, Sitnicka E, Storey C, Roth GJ, Bartelmez S. 1999. Sustained ex vivo expansion of hematopoieric stem cells mediated by thrombopoietin. Proc. Natl. Acad. Sci. USA 96:8126-31
96. Bryder D, Jacobsen SE. 2000. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 96:1748-55
97. Luskey BD, Rosenblatt M, Zsebo K, Williams DA. 1992. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80:396-402
98. Domen J, Weissman IL. 2000. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kit1/c-Kit signaling the other. J. Exp. Med. 192:1707-18
99. Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W. 1997. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89:3624-35
100. Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, et al. 2000. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:1365-72
101. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, et al. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notchl signaling. Nat. Med. 6:1278-81
102. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, et al. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2:172-80
103. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, et al. 2002. Over-expression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121-29
104. Morrison SJ, Prowse KR, Ho P, Weissman IL. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-16
105. Yui J, Chiu CP, Lansdorp PM. 1998. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91:3255-62
106. Brummendorf TH, Rufer N, Baerlocher GM, Roosnek E, Lansdorp PM. 2001. Limited telomere shortening in hematopoietic stem cells after transplantation. Ann. NY Acad. Sci. 938:1-8
107. Allsopp RC, Cheshier S, Weissman IL. 2001. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J. Exp. Med. 193:917-24
108. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. 1997. In vivo telomere dynamics of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 94:13782-85
109. Harrison DE, Astle CM, Delaittre JA. 1978. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J. Exp. Med. 147:1526-31
110. Harrison DE, Astle CM. 1982. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J. Exp. Med. 156:1767-79
111. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL. 1993. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. USA 90:3760-64
112. Harrison DE, Stone M, Astle CM. 1990. Effects of transplantation on the primitive immunohematopoietic stem cell. J. Exp. Med. 172:431-37
113. Domen J. 2001. The role of apoptosis in regulating hematopoietic stem cell numbers. Apoptosis 6:239-52
114. Domen J. 2000. The role of apoptosis in regulating hematopoiesis and hematopoietic stem cells. Immunol. Res. 22:83-94
115. Domen J, Cheshier SH, Weissman IL. 2000. The role of apoptosis in the regulation of hematopoietic stem cells: Over-expression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191:253-64
116. Aguila HL, Weissman IL. 1996. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 87:1225-31
117. Schneider E, Moreau G, Arnould A, Vasseur F, Khodabaccus N, et al. 1999. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood 94:2613-21
118. Maciejewski J, Selleri C, Anderson S, Young NS. 1995. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183-90
119. Takenaka K, Nagafuji K, Harada M, Mizuno S, Miyamoto T, et al. 1996. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 88:2871-77
120. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-36
121. Kawada H, Ogawa M. 2001. Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood 98:2008-13
122. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. 2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc. Natl. Acad. Sci. USA 99:1341-46
123. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-14
124. Butcher EC. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-36
125. Mazo IB, von Andrian UH. 1999. Adhesion and homing of blood-borne cells in bone marrow microvessels. J. Leukoc. Biol. 66:25-32
126. Mazo IB, Quackenbush EJ, Lowe JB, von Andrian UH. 2002. Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow. Blood 99:4182-91
127. Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD. 1998. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoieric progenitor homing to bone marrow. Proc. Natl. Acad. Sci. USA 95:14423-28
128. Jacobsen K, Kravitz J, Kincade PW, Osmond DG. 1996. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 87:73-82
129. Schweitzer KM, Drager AM, van der Valk P, Thijsen SF, Zevenbergen A, et al. 1996. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am. J. Pathol. 148:165-75
130. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. 1998. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91:4523-30
131. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195:1145-54
132. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-48
133. Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, et al. 1999. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J. Clin. Invest. 104:1199-211
134. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-94
135. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, et al. 2000. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106:1331-39
136. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-94
137. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, et al. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95:9448-53
138. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-99
139. Cashman J, Clark-Lewis I, Eaves A, Eaves C. 2002. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 99:792-99
140. Lataillade JJ, Clay D, Dupuy C, Rigal S, Jasmin C, et al. 2000. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 95:756-68
141. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, et al. 2000. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95:3289-96
142. Glimm H, Oh IH, Eaves CJ. 2000. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 96:4185-93
143. Potocnik AJ, Brakebusch C, Fassler R. 2000. Fetal and adult hematopoietic stem cells require betal integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 12:653-63
144. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. 1996. Impaired migration but not differentiation of haematopoietic stem cells in the absence of betal integrins. Nature 380:171-75
145. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. 1995. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92:9647-51
146. Wagers AJ, Allsopp RC, Weissman IL. 2002. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp. Hematol. 30:176-85
147. Arroyo AG, Taverna D, Whittaker CA, Strauch UG, Bader BL, et al. 2000. In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins. J. Immunol. 165:4667-75
148. Arroyo AG, Yang JT, Rayburn H, Hynes RO. 1999. Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity 11:555-66
149. Papayannopoulou T. 1999. Hematopoietic stem/progenitor cell mobilization. A continuing quest for etiologic mechanisms. Ann. NY Acad. Sci. 872:187-99
150. Morrison SJ, Wright DE, Weissman IL. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA 94:1908-13
151. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. 2001. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97:2278-85
152. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109:625-37
153. Prosper F, Stroncek D, McCarthy JB, Verfaillie CM. 1998. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 betal integrin expression and function. J. Clin. Invest. 101:2456-67
154. Craddock CF, Nakamoto B, Andrews RG, Priestley GV, Papayannopoulou T. 1997. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 90:4779-88
155. Papayannopoulou T, Nakamoto B. 1993. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. USA 90:9374-78
156. Papayannopoulou T. 2000. Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm. Semin. Hematol. 37:11-18
157. Pruijt JF, van Kooyk Y, Figdo RCG, Lindley IJ, Willemze R, Fibbe WE. 1998. Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood 91:4099-105
158. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, et al. 2001. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97:3354-60
159. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. 2001. Vascular cell adhesion molecule-1 (CD 106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98:1289-97
160. Levesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ. 2002. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30:440-49
161. Liu F, Poursine-Laurent J, Link DC. 2000. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood 95:3025-31
162. Pruijt JF, Verzaal P, van Os R, de Kruijf EJ, van Schie ML, et al. 2002. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. USA 99:6228-33
163. Brazelton TR, Rossi FM, Keshet GI, Blau HM. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775-79
164. Eglitis MA, Mezey E. 1997. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA 94:4080-85
165. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. 2000. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-82
166. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-94
167. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-30
168. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, et al. 1999. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. 199:391-96
169. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5
170. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98:10344-49
171. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, et al. 2001. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-402
172. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6:1229-34
173. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, et al. 1999. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-70
174. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, et al. 2000. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31:235-40
175. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, et al. 2000. Hepatocytes from non-hepatic adult stem cells. Nature 406:257
176. Perez LE, Rinder HM, Wang C, Tracey JB, Maun N, Krause DS. 2001.
177. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49
178. Ying QL, Nichols J, Evans EP, Smith AG. 2002. Changing potency by spontaneous fusion. Nature 416:545-48
179. Terada N, Hamazaki T, Oka M, Hold M, Mastalerz DM, et al. 2002. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542-45
180. Spooncer E, Heyworth CM, Dunn A, Dexter TM. 1986. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 31:111-18
181. Heyworth CM, Alauldin M, Cross MA, Fairbairn LJ, Dexter TM, Whetton AD. 1995. Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3. Br. J. Haematol. 91:15-22
182. Heberlein C, Fischer KD, Stoffel M, Nowock J, Ford A, et al. 1992. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation. Mol. Cell. Biol. 12:1815-26
183. Crotta S, Nicolis S, Ronchi A, Ottolenghi S, Ruzzi L, et al. 1990. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res. 18:6863-69
184. Jimenez G, Griffiths SD, Ford AM, Greaves MF, Enver T. 1992. Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. USA 89:10618-22
185. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, et al. 1997. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:774-85
186. Greaves M, Chan L, Furley A, Watt S, Molgaard H. 1986. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1-11
187. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, et al. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell 3:137-47
188. Nutt SL, Heavey B, Rolink AG, Busslinger M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-62
189. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, et al. 2000. The genetic program of hematopoietic stem cells. Science 288:1635-40
190. Wiesmann A, Phillips RL, Mojica M, Pierce LJ, Searles AE, et al. 2000. Expression of CD27 on murine hematopoieric stem and progenitor cells. Immunity 12:193-99
191. Park IK, He Y, Lin F, Laemm OD, Tian Q, et al. 2002. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 99:488-98
192. Terskikh AV, Easterday MC, Li L, Hood L, Kornblum HI, et al. 2001. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Prec. Natl. Acad. Sci. USA 98:7934-39
193. Orkin SH. 2000. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1:57-64
194. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, et al. 2000. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407:383-86
195. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, et al. 1996. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14:179-205
196. King AG, Kondo M, Scherer DC, Weissman IL. 2002. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc. Natl. Acad. Sci. USA 99:4508-13
197. Mikkola I, Heavey B, Horcher M, Busslinger M. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science 297:110-13
198. Graf T. 2002. Differentiation plasticity of hematopoietic cells. Blood 99:3089-101
199. Dexter TM, Allen TD, Lajtha LG. 1977. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell Physiol. 91:335-44
200. Weilbaecher K, Weissman I, Blume K, Heimfeld S. 1991. Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers. Blood 78:945-52
201. Gartner S, Kaplan HS. 1980. Long-term culture of human bone marrow cells. Proc. Natl. Acad. Sci. USA 77:4756-59
202. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, et al. 1990. Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417-26
203. Hao QL, Thiemann FT, Petersen D, Smogorzewska EM, Crooks GM. 1996. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 88:3306-13
204. Bosma MJ, Carroll AM. 1991. The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9:323-50
205. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-39
206. Kamel-Reid S, Dick JE. 1988. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706-9
207. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180-91
208. McCune JM. 1996. Development and applications of the SCID-hu mouse model. Semin. Immunol. 8:187-96
209. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-41
210. Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM. 1995. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J. Exp. Med. 182:2037-43
211. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, et al. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2:1329-37
212. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. 1997. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 94:5320-25
213. Ziegler BL, Valtieri M, Porada GA, De Maria R, Muller R, et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285:1553-58
214. Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, et al. 1997, Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NODscid mice. J. Immunol. 158:3578-86
215. Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, et al. 2000. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95:3102-5
216. Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, et al. 2000. NOD/LtSz-Raglnull mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164:2496-507
217. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. 2002. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-82
218. Mazurier F, Fontanellas A, Salesse S, Taine L, Landriau S, et al. 1999. A novel immunodeficient mouse model - RAG2 x common cytokine receptor gamma chain double mutants - requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon. Cytokine Res. 19:533-41
219. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ. 1998. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br. J. Haematol. 103:335-42
220. Flake AW, Harrison MR, Adzick NS, Zanjani ED. 1986. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 233:776-78
221. Srour EF, Zanjani ED, Brandt JE, Leemhuis T, Briddell RA, et al. 1992. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79:1404-12
222. Zanjani ED, Flake AW, Rice H, Hedrick M, Tavassoli M. 1994. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J. Clin. Invest. 93:1051-55
223. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz J-F, Shaper JH. 1984, Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal anti-body raised against KG-1a cells. J. Immunol. 133:157-65
224. Baumhueter S, Dybdal N, Kyle C, Lasky LA. 1994. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84:2554-65
225. Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T, 1995. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc. Natl. Acad. Sci. USA 92:12240-44
226. Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, et al. 1996. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 87:479-90
227. Krause DS, Fackler MJ, Civin CI, May WS. 1996. CD34: structure, biology, and clinical utility. Blood 87:1-13
228. DiGiusto D, Chen S, Combs J, Webb S, Namikawa R, et al. 1994. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84:421-32
229. Deaglio S, Mehta K, Malavasi F. 2001. Human CD38: a (r)evolutionary story of enzymes and receptors. Leukoc. Res. 25:1-12
230. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89:2804-8
231. Huang S, Terstappen LW. 1994. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood 83:1515-26
232. Hao QL, Smogorzewska EM, Barsky LW, Crooks GM. 1998. In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential. Blood 91:4145-51
233. Miller JS, McCullar V, Punzel M, Lemischka IR, Moore KA. 1999. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 93:96-106
234. Petzer AL, Hogge DE, Landsdorp PM, Reid DS, Eaves CJ. 1996. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc. Natl. Acad. Sci. USA 93:1470-74
235. Guenechea G, Gan OI, Dorrell C, Dick JE. 2001. Distinct classes of human stem cells that differ in proliferative and selfrenewal potential. Nat. Immunol. 2:75-82
236. Williams DA, Lemischka IR, Nathan DG, Mulligan RC. 1984. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310:476-80
237. Dick JE, Magli MC, Huszar D, Phillips RA, Bernstein A. 1985. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell 42:71-79
238. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, et al. 1988. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81:951-55
239. Bensinger WI, Buckner CD, Shannon-Dorcy K, Rowley S, Appelbaum FR, et al. 1996. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88:4132-38
240. Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, et al. 1996. Highly purified CD34-positive cells reconstitute hematopoiesis. J. Clin. Oncol. 14:2224-33
241. Link H, Arseniev L, Bahre O, Kadar JG, Diedrich H, Poliwoda H. 1996. Transplantation of allogeneic CD34+ blood cells. Blood 87:4903-9
242. Yabe H, Yabe M, Hattori K, Hinohara T, Morimoto T, et al. 1996. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors. Bone Marrow Transplant. 17:985-91
243. Michallet M, Philip T, Philip I, Godinot H, Sebban C, et al. 2000. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28:858-70
244. Negrin RS, Atkinson K, Leemhuis T, Hanania E, Juttner C, et al. 2000. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol. Blood Marrow Transplant. 6:262-71
245. Reisner Y, Bachar-Lustig E, Li HW, Aversa F, Velardi A, Martelli MF. 1999. The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. Ann. NY Acad. Sci. 872:336-50
246. Morel F, Galy A, Chen B, Szilvassy SJ. 1998. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells. Exp. Hematol. 26:440-48
247. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. 1998. Human bone marrow CD34-cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp. Hematol. 26:353-60
248. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4:1038-45
249. Fujisaki T, Berger MG, Rose-John S, Eaves CJ. 1999. Rapid differentiation of a rare subset of adult human lin(-) CD34(-)CD38(-) cells stimulated by multiple growth factors in vitro. Blood 94:1926-32
250. Nakamura Y, Ando K, Chargui J, Kawada H, Sato T, et al. 1999. Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood 94:4053-59
251. Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T 2000. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J. Clin. Invest. 106:263-70
252. Ito T, Tajima F, Ogawa M. 2000. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp. Hematol. 28:1269-73
253. Tajima F, Sato T, Laver JH, Ogawa M. 2000. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood 96:1989-93
254. Ogawa M. 2002. Changing phenotypes of hematopoietic stem cells. Exp. Hematol. 30:3-6
255. Okuno Y, Iwasaki H, Huettner CS, Radomska HS, Gonzalez DA, et al. 2002. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 99:6246-51
256. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. 1997. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-12
257. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. 2000. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95:2813-20
258. Berardi AC, Meffre E, Pflumio F, Katz A, Vainchenker W, et al. 1997. Individual CD34+CD 38lowCD 19-CD10-progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood 89:3554-64
259. Loken MR, Shah VO, Dattilio KL, Civin CI. 1987. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316-24
260. Grumayer ER, Griesinger F, Hummell DS, Brunning RD, Kersey JH. 1991. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7. Blood 77:64-68
261. Gore SD, Kastan MB, Civin CI. 1991. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 77:1681-90
262. Barcena A, Muench MO, Galy AH, Cupp J, Roncarolo MG, et al. 1993. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloid-cell development. Blood 82:3401-14
263. Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Insel RA. 1997. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood 89:929-40
264. Fluckiger AC, Sanz E, Garcia-Lloret M, Su T, Hao QL, et al. 1998. In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells. Blood 92:4509-20
265. Storms RW, Goodell MA, Fisher A, Mulligan RC, Smith C. 2000. Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood 96:2125-33
266. Galy A, Travis M, Cen D, Chen B. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459-73
267. Hao QL, Zhu J, Price MA, Payne KJ, Barsky LW, Crooks GM. 2001. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97:3683-90
268. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifes IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-26
269. Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, et al. 2001. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98:2256-65
270. Prieyl JA, LeBien TW. 1996. Interleukin 7 independent development of human B cells. Proc. Natl. Acad. Sci. USA 93:10348-53
271. Puel A, Ziegler SF, Buckley RH, Leonard WJ. 1998. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20:394-97
272. Roifman CM, Zhang J, Chitayat D, Sharfe N. 2000. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 96:2803-7
273. LeBien TW. 2000. Fates of human B-cell precursors. Blood 96:9-23
274. Manz MG, Miyamoto T, Akashi K, Weissman IL. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99:11872-77
275. Spits H, Blom B, Jaleco AC, Weijer K, Verschuren MC, et al. 1998. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol. Rev. 165:75-86
276. Lansdorp PM, Sutherland HJ, Eaves CJ. 1990. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J. Exp. Med. 172:363-66
277. Fritsch G, Buchinger P, Printz D, Fink FM, Mann G, et al. 1993. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood 81:2301-9
278. Olweus J, Lund-Johansen F, Terstappen LW. 1995. CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells. Blood 85:2402-13
279. Olweus J, Thompson PA, Lund-Johansen F. 1996. Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor. Blood 88:3741-54
280. Huang S, Chen Z, Yu JF, Young D, Bashey A, et al. 1999. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues. Stem Cells 17:265-72
281. Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, et al. 1997. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90:111-25
282. de Wynter EA, Heyworth CM, Mukaida N, Jaworska E, Weffort-Santos A, et al. 2001. CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors. J. Leukoc. Biol. 70:455-60
283. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, et al. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409:349-54
284. Ogawa M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844-53
285. Kimura T, Sakabe H, Tanimukai S, Abe T, Urata Y, et al. 1997. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Blood 90:4767-78
286. Bensinger WI, Buckner CD. 1999. Preparative regimens. See Ref. 321, pp. 123-34
287. Vose JM, Bierman PJ, Lynch JC, Atkinson K, Juttner C, et al. 2001. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol. Blood Marrow Transplant. 7:680-87
288. Uchida N, Tsukamoto A, He D, Friera AM, Scollay R, Weissman IL. 1998. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest. 101:961-66
289. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, et al. 2000. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N. Engl. J. Med. 342:1069-76
290. Antin JH. 1993. Graft-versus-leukemia: no longer an epiphenomenon. Blood 82:2273-77
291. Truitt RL, Johnson B, McCabe CM, Weiler MB. 1996. Graft-versus-leukemia. In Graft-vs.-Host Disease, ed. JLM Ferrara, J Deeg, SA Burakoff, pp. 385-423. New York: Marcel-Dekker
292. van den Brink MR, Burakoff SJ. 2002. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2:273-81
293. Ferrara J, Levy R, Chao N. 1999. Pathophysiologic mechanisms of acute graft-vs-host disease. Biol. Blood Marrow Transplant. 5:347-56
294. Deeg HJ, Storb R. 1984. Graft-versus-host disease: pathophysiological and clinical aspects. Annu. Rev. Med. 35:11-24
295. Chao NJ. 1997. Graft-versus-host disease: the viewpoint from the donor T cell. Biol. Blood Marrow Transplant. 3:1-10
296. Kernan NA. 1999. T-cell depletion for the prevention of graft-versus-host disease. See Ref. 321, pp. 186-96
297. Martin PF, Hansen FA, Buckner CD, Sanders EF, Deeg F, et al. 1985. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664-72
298. Shizuru JA, Jerabek L, Edwards CT, Weissman IL. 1996. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2:3-14. Erratum. 1997. Biol Blood Marrow Transplant. 3(1):50
299. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T. 1981. In vivo effect of anti-asialo GM1 anti-body on natural killer activity. Nature 291:334-35
300. Murphy WJ, Reynolds CW, Tiberghien P, Long DL. 1993. Natural killer cells and bone marrow transplantation. J. Natl. Cancer Inst. 85:1475-78
301. Lotzova E, Savary CA, Pollack SB. 1983. Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 35:490-94
302. Gandy KL, Domen J, Aguila H, Weissman IL. 1999. CD8+TCR+ and CD8+ TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 11:579-90
303. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. 1994. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84:2436-46
304. Martin PJ. 1993. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. Exp. Med. 178:703-12
305. Billingham RE, Brent L, Medawar PB. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-6
306. Gandy KL, Weissman IL. 1998. Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells. Transplantation 65:295-304
307. Shizuru JA, Weissman IL, Kernoff R, Masek M, Scheffold YC. 2000. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc. Natl. Acad. Sci. USA 97:9555-60
308. Jacobs P, Vincent MD, Martell RW. 1986. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant. 1:237-39
309. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. 1993. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J. Rheumatol. 20:137-40
310. Snowden JA, Patton WN, O'Donnell JL, Hannah EE, Hart DN. 1997. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant. 19:1247-50
311. Eedy DJ, Burrows D, Bridges JM, Jones FG. 1990. Clearance of severe psoriasis after allogenic bone marrow transplantation. Br. Med. J. 300:908
312. Yin JA, Jowitt SN. 1992. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant. 9:31-33
313. McAllister LD, Beatty PG, Rose J. 1997. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant. 19:395-97
314. Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes CJ, Dreyfus F. 1997. Remission of nonerosive polyarthritis associated with Sjogren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J. Rheumatol. 24:2466-68
315. Knaan-Shanzer S, Houben P, KinwelBohre EP, van Bekkum DW. 1991. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 8:333-38
316. van Gelder M, van Bekkum DW. 1996. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant. 18:1029-34
317. Karussis DM, Vourka-Karussis U, Lehmann D, Ovadia H, Mizrachi-Koll R, et al. 1993. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J. Clin. Invest. 92:765-72
318. Burt RK, Burns W, Ruvolo P, Fischer A, Shiao C, et al. 1995. Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 41:526-31
319. Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, et al. 2000. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356:701-7
320. Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L. 2003. Purified allogeneic hematopoietic stem cell transplantation blocks Diabetes pathogenesis in NOD mice. Diabetes. In press
321. Christianson SW, Shultz LD, Leiter EH. 1993. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42:44-55
322. Khouri I, Giralt S, Champlin R. 2002. Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy. Cancer Treat. Res. 110:137-47
323. Slavin S, Nagler A, Aker M, Shapira MY, Cividalli G, Or R. 2001. Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders. Rev. Clin. Exp. Hematol. 5:135-46
324. Storb RF, Champlin R, Riddell SR, Murata M, Bryant S, Warren EH. 2001. Non-myeloablative transplants for malignant disease. In Hematology, pp. 37591. Washington, DC: American Society of Hematology
325. Thomas ED, Blume KG, Forman SJ, eds. 1999. Hematopoietic Cell Transplantation. Malden, MA: Blackwell Sci.